Omega-3 fatty acids — specifically DHA and EPA — have been studied as a possible risk-reduction factor for postpartum depression, and the honest summary is: the evidence is real but inconsistent. Some randomized trials and meta-analyses find a meaningful reduction in depressive symptoms, particularly when supplementation starts after birth rather than during pregnancy. Other well-controlled trials find no effect at all. No study shows omega-3 supplementation treats, cures, or reliably prevents postpartum depression, and no responsible reading of this research supports using a supplement in place of screening or care from a doctor or mental health professional. What follows is what the trials actually measured — the encouraging findings and the null results both — plus what's known about omega-3 safety during pregnancy and breastfeeding, and what to do if you or someone you know is struggling right now.
What the research actually shows
The idea that omega-3 fatty acids might matter for postpartum mood didn't start with a clinical trial — it started with an observation. A widely cited cross-national analysis compared seafood consumption and the DHA content of breast milk across dozens of countries and found that higher fish/DHA intake tracked with lower reported rates of postpartum depression.1 That's an ecological correlation, not proof of cause and effect — diet, culture, healthcare access, and reporting all differ across countries too — but it's the observation that motivated the controlled trials that followed.
Those trials give a genuinely mixed picture, which is worth sitting with rather than smoothing over. A 2020 meta-analysis of 8 placebo-controlled randomized trials (638 women total) found a statistically significant, moderate benefit of omega-3 supplementation on perinatal depressive symptoms (standardized mean difference 0.65, 95% CI 0.10–1.20, p=0.02) — with the effect stronger in formulas higher in EPA relative to DHA, and stronger specifically in the postpartum period than during pregnancy itself.2 A separate, larger 2020 meta-analysis pooling 18 randomized trials (4,052 women) also found an overall small but significant benefit — and, importantly, broke the effect down by timing: the benefit was medium-to-large for supplementation aimed at postpartum depression, but negligible for supplementation started during pregnancy.3
Two meta-analyses point the same direction — a real but modest signal, strongest postpartum, weak during pregnancy itself. But the largest individual trials tell a different story.
Against that, two of the more rigorously controlled individual trials found nothing. The Mothers, Omega-3, and Mental Health Study (MOMS) randomized 126 pregnant women already considered at risk for depression to EPA-rich fish oil, DHA-rich fish oil, or placebo — and found no meaningful difference in depression scores between any of the groups, during pregnancy or after.4 A smaller Brazilian trial of 60 women given 1.8g/day of combined EPA+DHA from mid-pregnancy through early postpartum found the same null result overall — no difference in depression screening scores between the supplement and placebo groups — though a subgroup of women with a prior history of depression did show a statistically significant reduction in symptom scores, a result the study's own authors flagged as needing further, dedicated research rather than treated as confirmed.5
Why the studies disagree
A few real differences likely explain the split, rather than one set of trials being simply "wrong." Dose and EPA:DHA ratio varied a lot between trials, and the meta-analyses found higher-EPA formulas performed better — most of the null trials used DHA-dominant or lower-EPA blends. Timing mattered too: benefit showed up more consistently when supplementation targeted postpartum symptoms directly, rather than being started in pregnancy and measured months later. And baseline risk mattered — women with an existing depression history seemed to show more benefit than women supplemented as a general preventive measure regardless of risk. None of this adds up to a confirmed protocol; it's a set of open questions the current evidence points toward, not settled clinical guidance.
What this does — and doesn't — mean for you
It means omega-3/DHA supplementation has been studied as a possible adjunct or risk-reduction factor for postpartum depression, with real but inconsistent trial support — strongest for postpartum-targeted use, weakest for pregnancy-only use, and nowhere near strong enough to be called prevention or treatment on its own. It does not mean a fish oil supplement is a substitute for screening, therapy, or medication, and none of the trials above tested it as a replacement for those. If you're already working with a doctor or therapist on postpartum depression, omega-3 intake is a reasonable thing to mention as one factor among many — not a reason to delay or skip evaluation and care.
Pregnancy and breastfeeding: safety, and what our label actually says
Separately from the depression research, omega-3/DHA is one of the more reassuringly studied supplements for use during pregnancy and lactation as a general matter — DHA supports fetal brain and eye development, and the NIH's Office of Dietary Supplements notes adequate omega-3 intake is part of standard prenatal nutrition guidance.6 The main safety caution from NIH's National Center for Complementary and Integrative Health is about mercury from whole fish, not purified fish oil supplements specifically, and it's a food-sourcing issue more than a supplement one; the same guidance is clear that anyone using a complementary supplement during pregnancy should talk with their healthcare provider about it.7
Proco's Omega-3 (180mg EPA + 120mg DHA per serving) doesn't carry pregnancy- or breastfeeding-specific instructions on its physical label — the label's suggested use is one softgel twice daily as a general adult dose, with the standard "keep out of reach of children" and FDA supplement disclaimers. We don't want to imply otherwise. Our own product-page guidance is that omega-3 has a comparatively well-supported safety profile in pregnancy and breastfeeding, but that's still not the same as a green light without a conversation — particularly because prenatal vitamins often already contain DHA, and you don't want to unintentionally double up your total intake.8 Confirm with your OB-GYN, midwife, or doctor before adding this or any new supplement during pregnancy or while breastfeeding — bring your full supplement list, including your prenatal, to that conversation.
Bottom line
Omega-3/DHA supplementation has real, published research behind it as a possible risk-reduction factor for postpartum depression — two meta-analyses show a modest average benefit, concentrated in postpartum-onset use and higher-EPA formulas — but some of the best-controlled individual trials found no effect, and the evidence as a whole is genuinely mixed, not a settled case. Treat it as one small, reasonable factor to discuss with your doctor, never as a substitute for postpartum depression screening, therapy, or medication. If you're pregnant or breastfeeding, confirm any new supplement — including this one — with your OB-GYN or doctor first. And if you're struggling right now, please reach out: to your doctor, to a mental health professional, or, if you're in crisis, to 988 or emergency services immediately.
References
- Hibbeln JR. "Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis." Journal of Affective Disorders, 2002. pubmed.ncbi.nlm.nih.gov
- "The efficacy and safety of omega-3 fatty acids on depressive symptoms in perinatal women: a meta-analysis of randomized placebo-controlled trials." Translational Psychiatry, 2020. nature.com
- "Omega-3 Fatty Acid Supplementation for Perinatal Depression: A Meta-Analysis." Journal of Clinical Psychiatry, 2020. pubmed.ncbi.nlm.nih.gov
- Mozurkewich EL, et al. "The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial." American Journal of Obstetrics and Gynecology, 2013. pubmed.ncbi.nlm.nih.gov
- "Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial." BMC Pregnancy and Childbirth, 2017. pubmed.ncbi.nlm.nih.gov
- "Omega-3 Fatty Acids." NIH Office of Dietary Supplements, Consumer Fact Sheet. ods.od.nih.gov
- "Omega-3 Supplements: What You Need To Know." NIH National Center for Complementary and Integrative Health. nccih.nih.gov
- Proco Omega-3 EPA 180mg + DHA 120mg, product label and description. procohq.com
This article is for informational purposes only and has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Speak with a healthcare provider before starting any new supplement, especially if you take medication, are pregnant or breastfeeding, or have an existing health condition. Postpartum depression is a serious, treatable clinical condition — this article is not a substitute for screening, diagnosis, or care from a qualified doctor or mental health professional. If you are having thoughts of harming yourself or your baby, contact emergency services or a crisis line (988 in the US) immediately.
Related reading: Postpartum Brain Fog: What the Research Actually Says, Caffeine and Supplements During Pregnancy and Breastfeeding and Omega-3 and Depression: What the Clinical Research Actually Shows
Want to know what's actually in what you take? Join the list — no spam, just it straight.